Growing traction and growing team for Redbiotec’s oncology program

Redbiotec recently hired three additional scientists supporting Redbiotec’s fast growing oncology program. We are happy to observe a big and growing interest in Redbiotec’s COMOS and in Redbiotec’s engineered bacteria carrying CRISPR. As a consequence Redbiotec will invest further resources in these promising immuno-oncology platforms. Redbiotec is currently also evaluating additional people strengthening its scientific advisory board.

 

2018-06-05T12:22:33+00:00May 15th, 2018|Home, News|